CAPRICOR THERAPEUTICS, INC. (CAPR) › Capital ExpendituresCAPRICOR THERAPEUTICS, INC. (CAPR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $2.2K2011: $2.0K2012: $13.4K2013: $56.1K2014: $162.7K2015: $129.7K2016: $192.0K2017: $32.2K2018: $316.5K2019: $02020: $547.6K2021: $1.20M2022: $2.00M2023: $1.31M2024: $1.17M2025: $2.90M$2.90M2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$2.90M+148.9%2024$1.17M-11.0%2023$1.31M-34.4%2022$2.00M+67.2%2021$1.20M+118.5%2020$547.6K—2019$0-100.0%2018$316.5K+883.3%2017$32.2K-83.2%2016$192.0K+48.0%2015$129.7K-20.3%2014$162.7K+189.9%2013$56.1K+317.9%2012$13.4K+575.8%2011$2.0K-9.9%2010$2.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share